Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1986 1
1988 1
1989 1
1990 1
1995 1
1998 1
2011 1
2012 1
2013 3
2014 1
2015 1
2016 2
2017 1
2018 3
2019 1
2020 5
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease.
Berger T, Adamczyk-Sowa M, Csépány T, Fazekas F, Fabjan TH, Horáková D, Ledinek AH, Illes Z, Kobelt G, Jazbec SŠ, Klímová E, Leutmezer F, Rejdak K, Rozsa C, Sellner J, Selmaj K, Štouracˇ P, Szilasiová J, Turcˇáni P, Vachová M, Vanecková M, Vécsei L, Havrdová EK. Berger T, et al. Among authors: vachova m. Ther Adv Neurol Disord. 2020 Dec 7;13:1756286420975223. doi: 10.1177/1756286420975223. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 33335562 Free PMC article. Review.
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
Langford RM, Mares J, Novotna A, Vachova M, Novakova I, Notcutt W, Ratcliffe S. Langford RM, et al. Among authors: vachova m. J Neurol. 2013 Apr;260(4):984-97. doi: 10.1007/s00415-012-6739-4. Epub 2012 Nov 21. J Neurol. 2013. PMID: 23180178 Clinical Trial.
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.
Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, Gasperini C, Pozzilli C, Cefaro L, Comi G, Rossi P, Ambler Z, Stelmasiak Z, Erdmann A, Montalban X, Klimek A, Davies P; Sativex Spasticity Study Group. Novotna A, et al. Among authors: vachova m. Eur J Neurol. 2011 Sep;18(9):1122-31. doi: 10.1111/j.1468-1331.2010.03328.x. Epub 2011 Mar 1. Eur J Neurol. 2011. PMID: 21362108 Clinical Trial.
Routine clinical utility of honeybee venom allergen components.
Vachová M, Panzner P, Kopač P, Bidovec Stojkovič U, Korošec P. Vachová M, et al. J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2121-2123.e1. doi: 10.1016/j.jaip.2018.08.012. Epub 2018 Aug 31. J Allergy Clin Immunol Pract. 2018. PMID: 30176296 No abstract available.
Management of multiple sclerosis patients in central European countries: current needs and potential solutions.
Berger T, Adamczyk-Sowa M, Csépány T, Fazekas F, Hojs Fabjan T, Horáková D, Illes Z, Klimová E, Leutmezer F, Rejdak K, Rozsa C, Šega Jazbec S, Szilasiová J, Turčáni P, Vachová M, Vécsei L, Havrdová E. Berger T, et al. Among authors: vachova m. Ther Adv Neurol Disord. 2018 Feb 22;11:1756286418759189. doi: 10.1177/1756286418759189. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 29511382 Free PMC article. Review.
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS.
Horakova D, Rockova P, Jircikova J, Dolezal T, Vachova M, Hradilek P, Valis M, Sucha J, Martinkova A, Ampapa R, Grunermelova M, Stetkarova I, Stourac P, Mares J, Dufek M, Kmetova E, Adamkova J, Hrnciarova T. Horakova D, et al. Among authors: vachova m. Mult Scler Relat Disord. 2019 Oct;35:196-202. doi: 10.1016/j.msard.2019.08.003. Epub 2019 Aug 3. Mult Scler Relat Disord. 2019. PMID: 31400559
27 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page